These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 891477)

  • 1. [Serum prolactin level in healthy women and patients with functional disorders of the breast].
    Ozieblo L
    Endokrynol Pol; 1977; 28(4):323-30. PubMed ID: 891477
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of blood prolactin levels in breast diseases using prolactin radioimmunoassay kits (CIS-Prolak Kit)].
    Nakajima K; Saito K; Tobioka M; Ishihara K; Kobayashi T
    Horumon To Rinsho; 1976 Dec; 24(12):1303-10. PubMed ID: 1035518
    [No Abstract]   [Full Text] [Related]  

  • 3. [L-dopa and prolactin in breast neoplasms and dysplasia].
    Moguilevsky L; Scacchi P; Szwarcfarb B; Barbarelli J; Moguilevsky JA
    Medicina (B Aires); 1978; 38(1):27-30. PubMed ID: 713825
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].
    Gorins A; Netter A
    Nouv Presse Med; 1974 Jan; 3(2):73-5. PubMed ID: 4815434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pituitary hormone level in breast cancer patients].
    Agranat VZ; Valiura AV; Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma prolactin in breast cancer.
    Boyns AR; Cole EN; Griffiths K; Roberts MM; Buchan R; Wilson RG; Forrest AP
    Eur J Cancer (1965); 1973 Feb; 9(2):99-102. PubMed ID: 4717492
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the radio-immunological determination of somatotrophic hormone in benign and malignant mastopathy].
    Gorins A; Netter A; Encha F; Franchimont P
    Ann Endocrinol (Paris); 1970; 31(1):59-67. PubMed ID: 5462120
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Prolactin in benign and malignant breast disease.
    Cole EN; England PC; Sellwood RA; Griffiths K
    J Endocrinol; 1976 Jun; 69(3):49P-50P. PubMed ID: 950543
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum prolactin concentrations in benign breast disease throughout the menstrual cycle.
    Cole EN; Sellwood RA; England PC; Griffiths K
    Eur J Cancer (1965); 1977 Jun; 13(6):597-603. PubMed ID: 880967
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 11. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of plasma prolactin to 17-B oestradiol in women with tumours of the breast.
    Jones MK; Ramsay ID; Collins WP; Dyer GI
    Eur J Cancer (1965); 1977 Oct; 13(10):1109-12. PubMed ID: 923610
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on human prolactin radioimmunoassay kit and serum prolactin responses to TRH in thyroid and other endocrine disorders].
    Matsumura S; Oyama H; Tenku A; Nishida S; Horino M
    Radioisotopes; 1977 Apr; 26(4):248-51. PubMed ID: 408883
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating levels of prolactin in human breast cancer.
    Sheth NA; Ranadive KJ; Suraiya JN; Sheth AR
    Br J Cancer; 1975 Aug; 32(2):160-7. PubMed ID: 2274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
    Bischoff J; Rebhan EM; Prestele H; Becker H
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):65-71. PubMed ID: 7353778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
    Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian mesor-hyperprolactinemia in fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Am J Med; 1979 Feb; 66(2):229-37. PubMed ID: 425966
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma prolactin in women with mastodynia.
    Graziottin A; Sopracordevole F; Velasco M; Grella PV
    Clin Exp Obstet Gynecol; 1984; 11(3):113-6. PubMed ID: 6539179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin 2 (IL-2) levels and prolactin bioactive/radioimmunoassay ratios of women at risk for breast cancer.
    Gala RR; Martino S; Wiejowski SA; Kresge CL; Alonso MM
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1603-5. PubMed ID: 2591452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies of blood prolactin].
    Shimizu N; Yoshida N; Joko J; Arakawa M
    Horumon To Rinsho; 1976 Oct; 24(10):1033-40. PubMed ID: 1034506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.